HCID 66597460, compound → 4-[1-(1-Cyclopentyl-4,4-difluorobutyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]-pyrimidine trifluoroacetate salt
Reaction equation
[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH:8]1([CH:13]([N:19]2[CH:23]=[C:22]([C:24]3[C:25]4[CH:32]=[CH:31][NH:30][C:26]=4[N:27]=[CH:28][N:29]=3)[CH:21]=[N:20]2)[CH2:14][CH:15]=[C:16]([F:18])[F:17])[CH2:12][CH2:11][CH2:10][CH2:9]1>CO.[Pd]>[F:1][C:2]([F:7])([F:6])[C:3]([OH:5])=[O:4].[CH:8]1([CH:13]([N:19]2[CH:23]=[C:22]([C:24]3[C:25]4[CH:32]=[CH:31][NH:30][C:26]=4[N:27]=[CH:28][N:29]=3)[CH:21]=[N:20]2)[CH2:14][CH2:15][CH:16]([F:17])[F:18])[CH2:12][CH2:11][CH2:10][CH2:9]1Participants
4
Procedure
4-[1-(1-Cyclopentyl-4,4-difluorobut-3-en-1-yl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]-pyrimidine trifluoroacetate salt (prepared as in Example 731) (20.0 mg, 0.041 mmol) was dissolved in methanol (3 mL), and a catalytic amount of 5% Pd on C was added. The mixture was stirred at room temperature for 2 hours, under an atmosphere of hydrogen provided by an affixed balloon. The mixture was filtered and purified via preparative-HPLC/MS (C18 eluting with a gradient of H2O and ACN containing 0.1% TFA) to afford product (4 mg, 21%).
Workup
- customprovided by an affixed balloon
- filtrationThe mixture was filtered
- custompurified via preparative-HPLC/MS (C18
- washeluting with a gradient of H2O and ACN containing 0.1% TFA)
Sources & evidence
- ORD record
- ord-0e1501c6d3bf46669ab02a5cc568991f
- Source dataset
- uspto-grants-2013_09
- Patent number
- US08530485B2
Reaction notes
Loading…